Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01944748 · ClinicalTrials.gov registry record · NA
Family Mediation Program For At-Risk Youth
A NA study, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT01944748: Completed NA study, sponsored by RAND.
NCT01944748 is a NA study that has completed, run by RAND. The registered enrollment target is 111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01944748, a NA study, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
The goal of this project is to conduct a pilot evaluation of a parent-child mediation program for at-risk youth. It is investigating whether families who receive parent-child mediation show greater improvement in family functioning, as well as adolescent substance use, academic performance, and delinquency, over a 6-week and 12-week period compared to a wait-list control sample.
Primary Outcome
6-item Positive Family Relations measure adapted from the Cohesion subscale of Moos \& Moos Family Environment Scale (Metzler et al., 1998; Journal of Family Psychology, 12, 600-619). Items are rated on a 5-point scale ("not at all" to "very much") and averaged to create a scale score.
Interventions
- BEHAVIORAL Families Able To Resolve Situations (FARS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2011-07 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT01944748 record still lists
NCT01944748 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Families Able To Resolve Situations (FARS) is the first listed.
NCT01944748 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01944748 about?
NCT01944748 is a clinical study titled "Family Mediation Program For At-Risk Youth". The goal of this project is to conduct a pilot evaluation of a parent-child mediation program for at-risk youth. It is investigating whether families who receive parent-child mediation show greater improvement in family functioning, as well as adolescent substance use, academic performance, and deli...
What is the current status of trial NCT01944748?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2011-07. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01944748?
The interventions under investigation include: Families Able To Resolve Situations (FARS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01944748?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01944748's enrollment target sits among peer trials
111 816th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia